Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 23.00 |
| Open | 23.08 |
| Bid | 22.56 x 1000 |
| Ask | 23.51 x 1000 |
| Day's Range | 22.92 - 23.35 |
| 52 Week Range | 18.05 - 31.78 |
| Volume | |
| Avg. Volume | 1,026,508 |
| Market Cap | 3.098B |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.80 |
| Earnings Date | May 03, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 54.43 |
- Zacks
Is the Options Market Predicting a Spike in Vir Biotechnology (VIR) Stock?
Investors need to pay close attention to Vir Biotechnology (VIR) stock based on the movements in the options market lately.
- Simply Wall St.
Strong week for Vir Biotechnology (NASDAQ:VIR) shareholders doesn't alleviate pain of three-year loss
For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...
- GlobeNewswire
Vir Biotechnology to Participate in the Barclays Global Healthcare Conference
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., Executive Vice President, Chief Medical Officer and Interim Head of Research, is scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 15, at 7:15 a.m. PT / 10:15 a.m. ET. A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived the
© 2023 Yahoo. All rights reserved.
